AI assistant
LISATA THERAPEUTICS, INC. — Director's Dealing 2011
Mar 8, 2011
34931_dirs_2011-03-08_73c7874c-355a-4756-8086-07898b8301a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-03-04
Reporting Person: Kolbert Jason (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-04 | Stock Options (right to buy) | $1.49 | A | 350000 | Acquired | 2021-03-03 | Common Stock, par value $0.001 per share (350000) | Direct |
Footnotes
F1: On March 4, 2011, the commencement date ("Commencement Date") of his employment agreement with NeoStem, Inc. (the "Company"),
the reporting person was granted an option to purchase 350,000 shares of common stock, par value $0.001 per share, of the
Company, pursuant and subject to the terms and conditions of the Company's 2009 Equity Compensation Plan. This option
vested as to 50,000 shares on the Commencement Date, and is scheduled to vest as to 100,000 shares on each of March 4, 2012,
March 4, 2013 and March 4, 2014, provided that the reporting person remains employed by the Company on each of such dates.